Stephen R Durham is an expert in Immunology at Royal Brompton Hospital (United Kingdom). As of September 2026, ScienceLeadR ranks Stephen R Durham in the top 1% of experts worldwide for Rhinitis, Nose Diseases and Hypersensitivity. Stephen R Durham has authored 702 publications, the most recent in 2026, and is an investigator in 12 clinical trials, 1 of them ongoing. SLR score: 2,547 (community average: 125). How the SLR is computed.

LeadR Profile

Stephen R Durham Royal Brompton Hospital United Kingdom
2 547 ScienceLeadR Reputation 2547
Network Map

Immunology

Subspecialties: Allergy - Pulmonology - Internal Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1988 - 2026

Source: PubMed

Imperial College London

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 702

Citations

Citations: 72 482 1st author: 58 Last author: 210 Unique author: 30


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Fel d 1-Expressing Plant-Derived Bioparticle: A Novel Treatment for Cat Allergy.
PMID 41856757 — skin, cells, hypersensitivity, basophils, allergens, therapeutics, allergy
Allergy20260
Differential effects of subcutaneous and sublingual immunotherapy on Timothy grass-specific Th2 CD4 + T cell subsets.
PMID 41780572 — cells, sublingual immunotherapy, hypersensitivity, phenotype, allergens, immunotherapy, cluster analysis, t-lymphocytes, t-lymphocyte subsets
J Allergy Clin Immunol20260
Comparative Efficacy of Biologicals for Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review and Bayesian Network Meta-Analysis.
PMID 41685942 — hypersensitivity, adrenal cortex hormones, polyps, network meta-analysis, antibodies, monoclonal, nasal polyps, rhinosinusitis
Clin Exp Allergy20260
East Meets West in Allergic Airway Disease: Insights From the EAACI Hong Kong Allergy School 2025.
PMID 41454649 — hypersensitivity, schools, allergy
Allergy20250
The clinical effectiveness of clarithromycin versus endoscopic sinus surgery for adults with chronic rhinosinusitis with and without nasal polyps (MACRO): a pragmatic, multicentre, three-arm, randomised, placebo-controlled phase 4 trial.
PMID 40885584 — therapeutic irrigation, clarithromycin, adrenal cortex hormones, polyps, drug-related side effects and adverse reactions, therapeutics, nasal polyps, rhinosinusitis
Lancet Top journal20255

Clinical Studies 12

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 4 Study Chair: 1

By phase:

Phase 2 4
Phase 3 4
N/A 2
Phase 1 1
Phase 2/Phase 3 1

By status:

Completed 9
Unknown 2
Recruiting 1

By type:

Interventional 11
Observational 1

By Monocentric/Multicentric:

monocentric 8
multicentric2to4 3
multicentric5to9 1
multicentricup10 0

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
HDM and Silver Birch NAC Standardisation
NCT05378594 — dust, rhinitis, allergic, tablets, allergens, signs and symptoms, rhinitis
N/ARecruiting2022

LeadR Networks

Main global connection map